|
Worldwide Biotech
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
Total result: 357 articles |
 Page 3 of 5 
|
UPSTATE GROUP/CXR BIOSCIENCES DEVELOPING IN VITRO SCREENS.
August 01, 2005
NEUROBIOLOGICAL TECHNOLOGIES SIGNS VIPRINEX PACTS.
August 01, 2005
PHARMASSET TO DEVELOP CLEVUDINE FOR HEPATITIS B.
August 01, 2005
SFDA GRANTS MIRACLE LASER APPROVAL TO SELL SYNERON PRODUCTS.
July 01, 2005
BIOCUREX/GOSHEN CANCER CENTER DEVELOPING RECAF.
July 01, 2005
NEWLY-ENGINEERED SYNTHETIC AFGP STABLE/NON-TOXIC.
July 01, 2005
ISOLAGEN UNVEILS AUTOMATED CELLULAR EXPANSION SYSTEM.
July 01, 2005
STUDIES SUPPORT LIPID SCIENCES VIRAL IMMUNOTHERAPY PLATFORM.
June 01, 2005
GPC BIOTECH PRESENTS NEW SATRAPLATIN DATA AT AACR.
June 01, 2005
QIAGEN LAUNCHES PRODUCT PORTFOLIO FOR RNAI/SYBR RT-PCR.
June 01, 2005
RECAF BLOOD TEST DETECTS 92% OF CERVICAL CANCERS.
June 01, 2005
TB ALLIANCE/GLAXOSMITHKLINE TO DEVELOP TB THERAPIES.
May 01, 2005
CRUCELL/DSM SIGN LICENSING PACT WITH MITSUBISHI PHARMA.
May 01, 2005
INDIA AND CII SUPPORT AETHLON HIV/HEPATITIS TRIALS.
May 01, 2005
ALLERGAN/SANWA KAGAKU KENKYUSHO TO DEVELOP POSURDEX IN JAPAN.
May 01, 2005
MONSANTO ENCOURAGED BY BRAZILIAN BIOSAFETY LAW.
May 01, 2005
OCTOPLUS\BIOLEX DEVELOPING LOCTERON.
April 01, 2005
CRYPTOME GETS OPTION FOR ANTI-INFLAMMATORY DRUG LICENSE.
April 01, 2005
U.S. BIODEFENSE/UCL BIOMEDICA GET OPTION TO LICENSE PATENT.
April 01, 2005
IMUGENE RECEPTOR MIMIC TECHNOLOGY PATENT GRANTED IN U.S.
March 01, 2005
AVEXA IN-LICENSES PHASE II HIV DRUG FROM SHIRE.
March 01, 2005
ARGENTA/NOVARTIS SIGN TWO-YEAR DRUG DISCOVERY PACT.
March 01, 2005
TOPICAL TRIAL OF MELANOTAN GETS UK REGULATORY APPROVAL.
March 01, 2005
GPC BIOTECH/DEBIOPHARM SIGN MHC II ANTAGONISTS LICENSE PACT.
February 01, 2005
THERATECHNOLOGIES GETS US $12 MILLION FOR MACROFLUX.
February 01, 2005
CANGENE COMPLETES MRP FOR WINRHO SDF APPROVAL IN 10 COUNTRIES.
February 01, 2005
BIOSIGNAL AWARDED $1.377 M FOR ANTI-BACTERIAL CONTACT LENSES.
February 01, 2005
SOMAXON EXERCISES OPTION TO LICENSE NALMEFENE.
January 01, 2005
LIBRACOL AVAILABLE AT SOME 500 ADDITIONAL OUTLETS.
January 01, 2005
LORUS SIGNS VIRULIZIN SUPPLY PACT WITH BIOVECTRA.
January 01, 2005
ANTISENSE TO INITIATE "PROOF OF CONCEPT" STUDY OF ATL1101.
January 01, 2005
NOVADEL SELECTS INYX TO PRODUCE NITROGLYCERIN LINGUAL SPRAY.
January 01, 2005
DYNOGEN ACQUIRES EXCLUSIVE RIGHTS TO PUMOSETRAG.
December 01, 2004
LIPONEX GRANTED U.S. PATENT ALLOWANCE FOR CRD5.
December 01, 2004
NOBEX/BIOCON TO DEVELOP ORAL INSULIN PRODUCT.
December 01, 2004
CRUCELL/MERIAL SIGN LICENSE PACT FOR PER.C6 TECHNOLOGY.
December 01, 2004
SEOUL HOSPITAL SELECTS ELEKTA MEG EQUIPMENT.
December 01, 2004
ABLYNX AND GENENCOR FORM ONCOLOGY COLLABORATION.
November 01, 2004
VALEANT MARKETS LESCARDEN'S CATRIX7 WOUND DRESSING.
November 01, 2004
BIOSIGNAL/IER REPORT 100% ANTI-BACTERIAL EFFICACY OF LENSES.
November 01, 2004
ROCHE/GLYCART TO DISCOVER NEW THERAPEUTIC ANTIBODIES.
November 01, 2004
GENE EXPRESS TECHNOLOGY RECEIVES INTERNATIONAL PATENTS.
November 01, 2004
SURFAXIN GETS ORPHAN DRUG DESIGNATION FROM EMEA.
October 01, 2004
GENEPHARM BEGINS REGISTRATION OF FIVE ANTI-CANCER DRUGS.
October 01, 2004
CRUCELL LICENSES PER.C6 TECHNOLOGY TO GLAXOSMITHKLINE.
October 01, 2004
AVIAN INFLUENZA VACCINE TRIALS INITIATED IN AUSTRALIA.
October 01, 2004
MERRIMACK COMPLETES ENROLLMENT FOR MM-093 PHASE IIA.
October 01, 2004
EPITAN ACQUIRES THREE DERMATOLOGY PRODUCTS.
September 01, 2004
UK FETAL MEDICINE FOUNDATION APPROVES DELFIA PRENATAL ASSAYS.
September 01, 2004
UNIGEN/INCA HEALTH TO DEVELOP PLANT-DERIVED HEALTH PRODUCTS.
September 01, 2004
AUSTCANCER APPOINTS SINGAPORE DISTRIBUTOR FOR REVISYS.
September 01, 2004
KINEXUS VALIDATES PLK1 AS CANCER DRUG TARGET.
September 01, 2004
DECODE INITIATES PHASE IIA CLINICAL TRIAL FOR DG031.
August 01, 2004
RANBAXY LAUNCHES RANICLOR CHEWABLE CEPHALOSPORIN TABLET.
August 01, 2004
AMRAD TO DEMERGE ANTI-INFECTIVES BUSINESS.
August 01, 2004
VERTEX/MITSUBISHI TO DEVELOP HCV ORAL PROTEASE INHIBITOR.
August 01, 2004
GPC BIOTECH GETS U.S. PATENT FOR ANTI-CANCER CELL INHIBITOR.
August 01, 2004
PROMETIC BIOSCIENCES ACHIEVES SECOND MILESTONE OF LICENSE.
July 01, 2004
BTG GETS EXCLUSIVE LICENSE TO NEW CLASS OF CANCER DRUG.
July 01, 2004
UNIGEN/UNIV. OF PANAMA SIGN PLANT COLLECTION PACT.
July 01, 2004
AUSTCANCER TO ACQUIRE U.S. VACCINE DEVELOPER.
July 01, 2004
FDA GRANTS TENTATIVE APPROVAL OF SICOR'S FLUMAZENIL INJECTION.
June 01, 2004
US ONCOLOGY CENTER OFFERS AUSTCANCER'S REVISYS SUPPLEMENTS.
June 01, 2004
ANIKA INITIATES INCERT-S ANTI-ADHESION THERAPY CLINICAL TRIAL.
June 01, 2004
DRAGON GETS HUMAN G-CSF LICENSING RIGHTS EXCLUDING CHINA.
June 01, 2004
NOVARTIS SANDOSTATIN LAR APPROVED IN JAPAN FOR ACROMEGALY.
June 01, 2004
AERAS/CRUCELL TO DEVELOP TB VACCINE.
May 01, 2004
EVOTEC OAI/PANACOS TO DEVELOP ANTI-HIV THERAPIES.
May 01, 2004
AVIDEX APPOINTS ULTRAFINE TO DEVELOP/MANUFACTURE RHUDEX.
May 01, 2004
OREXO PATENT FOR RAPID DELIVERY ISSUED IN EU.
May 01, 2004
ROCHE SELECTS TWO GENMAB ANTIBODIES AS CLINICAL CANDIDATES.
May 01, 2004
GBC BIOTECH PRESENTS NEW DATA ON EFFICACY OF SATRAPLATIN.
April 01, 2004
NEXMED LICENSES FEMPROX TO CJ CORP. FOR SOUTH KOREA.
April 01, 2004
DXS AND SANGTEC SIGN SCORPIONS TECHNOLOGY LICENSE PACT.
April 01, 2004
EPT'S IMPLANT TRIAL EXCEEDS EXPECTATION.
April 01, 2004
|
